1. ALLA AKTIER
  2. NYHETER
  3. SENZAGEN

SenzaGen

Nyheter SenzaGen Nyheter alla bolag

Invitation to the presentation of SenzaGen's year-end report 2024 on Feb 13 at 12.00

SenzaGen's 2024 year-end report will be published on February 13, 2025, at 08:30 AM, followed by a live webcast presentation at 12:00 on the same day. The presentation will be given by SenzaGen's President and CEO, Peter Nählstedt, with a subsequent Q&A session moderated by Redeye's analyst Gustaf Meyer.

The presentation will be held in English.

Time: Thursday, February 13, from 12:00 to 13:00.
Link to webcast: https://www.redeye.se/events/1071217/live-q-senzagen-3

The presentation can also be viewed later on SenzaGen's website: https://senzagen.com/investors/presentations/

Contacts

Peter Nählstedt, President and CEO, SenzaGen AB
Email: peter.nahlstedt@senzagen.com | Mobile: +46 700 23 44 31

Tina Dackemark Lawesson, VP Marketing & Communications
Email: tina.lawesson@senzagen.com | Mobile: +46 708 20 29 44

About us

SenzaGen is a corporate group that aims to be a leader in in vitro science and testing, driving the transition from animal testing to methods better suited to reflect human biology. The Company provides high-performance, non-animal test methods and innovation and consulting services based on state-of-the-art technology. Non-animal methods are more effective, more accurate and less expensive than traditional animal-based methods while also helping to reduce the number of laboratory animals. The Company has a growth strategy centered around continued commercialization of its proprietary GARD® and VitroScreen ORA® test platforms, expansion of its test portfolio and evaluation of acquisition opportunities of profitable and growing companies with complementary offerings. SenzaGen has its headquarters and GLP-certified laboratory in Lund, Sweden and subsidiaries in the US and Italy. For more information, please visit: www.senzagen.com.

SenzaGen is listed on Nasdaq Stockholm First North (ticker: SENZA). FNCA Sweden AB is the company’s Certified Adviser. 

Attachments

Invitation to the presentation of SenzaGen's year-end report 2024 on Feb 13 at 12.00

Datum 2025-02-06, kl 08:30
Källa MFN
Bifogade filer
Invitation to the presentation of SenzaGen's year-end report 2024 on Feb 13 at 12.00
Affiliate
SAVR är investeringsplattformen som utmanar branschen och gör det både enklare och roligare att investera. Betala aldrig för mycket! Alla aktier och ETF:er från 1 kr, och få upp till 50 % rabatt på alla fonder. Automatiskt courtage och samma enkla prismodell på alla marknader.
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet